NL-OMON52473已完成不适用
iquid biopsies and imaging - LIMA
niversitair Medisch Centrum Utrecht0 个研究点目标入组 100 人开始时间: 待定最近更新:
适应症
试验速览
- 阶段
- 不适用
- 状态
- 已完成
- 发起方
- 入组人数
- 100
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Observational
入排标准
- 年龄范围
- 18 至 64（—）
入选标准
- •- Female patients aged 18 years or older
- •- Histologically proven invasive breast carcinoma
- •- Planned for neoadjuvant chemotherapy (and in case of a Her2-positive
- •tumor: addition of trastuzumab and/or pertuzumab)
排除标准
- •- ER-positive, HER2-negative, B&R grade 1 breast cancer
- •- Inflammatory breast cancer
- •- Distant metastases on PET/CT
- •- Ipsilateral breast cancer in history (contralateral breast cancer >5 years
- •ago is allowed)
- •- Other active malignant disease in the past 5 years (excluded squamous cell or
- •basal cell carcinoma of the skin)
- •- Pregnant or lactating women.
- •- Contra-indications for MRI according to standard hospital guidelines.
- •- Contra-indications for gadolinium-based contrast-agent, including known prior
- •allergic reaction to any contrastagent, and renal failure, defined by GFR < 30
- •mL/min/1.73m2.
研究者
相似试验
已完成
不适用
iquid Biopsies for minimally invasive Detection of Acute Rejectioorgaantransplantatiegraft rejectiontransplant rejectionNL-OMON50673Erasmus MC, Universitair Medisch Centrum Rotterdam450
尚未招募
不适用
iquid biopsies for CNS tumors10029211brain tumorNL-OMON53668Erasmus MC, Universitair Medisch Centrum Rotterdam20
已完成
不适用
A liquid biopsy study of recurrent gastric/gastroesophageal junction cancergastric or gastroesophageal junction cancerJPRN-UMIN000043080St.Marianna University School of Medicine50
进行中（未招募）
不适用
Liquid Biopsies and IMAging for Improved Cancer CareRectal CancerNCT04224779Institut du Cancer de Montpellier - Val d'Aurelle16
进行中（未招募）
Unknown
iquid biopsy testing in the diagnosis of lung cancerPatients with suspected stage III (excluding radical treatment) and IV lung cancer based on computer tomography (CT scan) and have tissue biopsy (SOC) diagnostic testing plannedCancerISRCTN22734699Aneurin Bevan University Health Board1,260